GI
ORIC icon

GAMMA Investing’s Oric Pharmaceuticals ORIC Stock Holding History

GAMMA Investing’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62K Sell
334
-218
-39% -$1.98K ﹤0.01% 3602
2026
Q1 		$6.99K Buy
552
+49
+10% +$556 ﹤0.01% 3232
2025
Q4 		$4.12K Buy
503
+93
+23% +$1.07K ﹤0.01% 3363
2025
Q3 		$4.92K Buy
410
+74
+22% +$779 ﹤0.01% 3191
2025
Q2 		$3.41K Sell
336
-371
-52% -$2.49K ﹤0.01% 3252
2025
Q1 		$3.94K Buy
707
+558
+374% +$4.88K ﹤0.01% 3179
2024
Q4 		$1.2K Buy
149
+106
+247% +$973 ﹤0.01% 3369
2024
Q3 		$441 Sell
43
-36
-46% -$356 ﹤0.01% 3411
2024
Q2 		$559 Buy
79
+49
+163% +$439 ﹤0.01% 3192
2024
Q1 		$413 Buy
+30
New +$356 ﹤0.01% 3133

Other funds holding ORIC

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's ORIC Position: Q2 2026 in Review

GAMMA Investing reduced its Oric Pharmaceuticals (ORIC) stake by 39% in Q2 2026, selling an estimated $1.98K and leaving 334 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #3602.

GAMMA Investing first reported a position in ORIC in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.99K in Q1 2026. 6 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • GAMMA Investing held 334 shares of Oric Pharmaceuticals worth $3.62K as of Q2 2026.
  • GAMMA Investing sold 218 Oric Pharmaceuticals shares in Q2 2026, an estimated $1.98K.
  • Oric Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3602 holding.
  • GAMMA Investing first reported a position in Oric Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • GAMMA Investing's Oric Pharmaceuticals position peaked at $6.99K in Q1 2026.
  • 6 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.